We now know that the substance originally termed slow-reacting substance of anaphylaxis was composed of three cysteinyl leukotrienes that act in the inflammatory response via receptors on smooth ...

Cysteinyl leukotriene receptors (CysLTRs) are a group of receptors that play a significant role in various inflammatory processes in the body. Recent research has increasingly focused on their ...

Montelukast is a cysteinyl leukotriene receptor antagonist, meaning it blocks the site in the airways where the leukotrienes work. Montelukast can't be used to treat acute asthma (an asthma attack), ...

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...

Montelukast is a cysteinyl leukotriene receptor antagonist, meaning it blocks the site in the airways where the leukotrienes work. Montelukast can't be used to treat acute asthma (an asthma attack ...

Conventional treatments for allergic rhinitis may also improve asthma outcomes in patients with both conditions. Read now!

by other drugs including leukotriene receptor antagonists and chromones. Tolerance from daily use of IβA is of concern and more flexible drug therapy needs to be considered. Optimal use of ...